Immunology News and Research

Latest Immunology News and Research

New cost-effective liquid solution can help fight antibiotic-resistant bacteria

According to the World Health Organization, antibiotic-resistant bacteria are one of the top three threats to human health. Patients in hospitals are especially at risk, with almost 100,000 deaths due to infection every year in the U.S. alone.

12 Dec 2011

Study describes miR-124 can prevent and treat liver cancer

Cancer of the liver - rare in the United States but the third-leading cause of cancer death worldwide - can result from environmental exposures or infections like chronic hepatitis, but the link is poorly understood.

12 Dec 2011

New guidelines for managing latent tuberculosis from CDC

The U.S. Centers for Disease Control and Prevention (CDC) has released new guidelines on treating so-called “latent” tuberculosis (TB) infection in the United States. They suggest the course of the therapy from about 9 months could be shortened to 3 months.

11 Dec 2011

High gut flora protects children against allergies

High diversity and a variety of bacteria in the gut protect children against allergies as opposed to some individual bacterial genera. These are the findings of a comprehensive study of intestinal microflora (gut flora) in allergic and healthy children, which was conducted at Linköping University in Sweden.

9 Dec 2011

Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has executed an agreement with Pharmacyclics, Inc. to jointly develop and market the anti-cancer compound, PCI-32765.

9 Dec 2011

Recommendations to address challenges associated with chronic inflammatory diseases

A dramatic increase in the incidence of chronic inflammatory diseases such as asthma, allergy, and irritable bowel syndrome, has led to concern about how modern lifestyles may trigger physiological defense mechanisms.

8 Dec 2011

Janssen Biotech, Molecular Partners collaborate to develop DARPins for immunological diseases

Molecular Partners AG today announced that it has entered into a strategic research collaboration and option agreement with Janssen Biotech, Inc. to research, discover and develop DARPin products for the treatment of immunological diseases.

8 Dec 2011

Vaccine against Ebola developed

Ebola was first identified in 1976 in Sudan and Zaire, which is now the Democratic Republic of the Congo and Ebola fever kills more than 90% of the people it infects. Ebola is among the most lethal diseases known to humans, according to the World Health Organization.

7 Dec 2011

Milk powder outperforms lower-dose therapy for treatment of food allergies

A small study by researchers at the Johns Hopkins Children's Center and Duke University shows that eating higher doses of milk protein in the form of dry powder substantially outperforms lower-dose therapy — a few drops of liquid milk extract under the tongue — for treatment of food allergies.

7 Dec 2011

Advancing the development of a malaria transmission-blocking vaccine

Three leaders in malaria vaccine development announced today a collaboration to evaluate a potential vaccine candidate designed to prevent transmission of malaria from mosquitoes to humans—a type of vaccine that researchers think could contribute to the eventual eradication of malaria.

6 Dec 2011

More mothers are breastfeeding their newborns, but for too short a duration

More mothers are breastfeeding their newborns, but for too short a duration to gain the maximum benefits of breastfeeding for both mothers and infants.

6 Dec 2011

Headaches after TBI more prevalent among adolescents, girls

More than half a million children in the U.S. sustain a traumatic brain injury (TBI) every year. Adults who suffer TBI often report headaches afterward, but little is known about how often children suffer headaches after similar injuries. In a significant new study, "Headache After Pediatric Traumatic Brain Injury: A Cohort Study," researchers analyzed the prevalence of headaches three and 12 months after mild, moderate or severe TBI in children ages 5 to 17, and discovered the risk of headache was higher in adolescents (ages 13 to 17) and in girls.

6 Dec 2011

Dust storms have adverse effect on hospital EDs for COPD

A new study published in the journal Respirology reveals that dust storms have an adverse effect on emergency hospital admission for chronic lung disease, often known as chronic obstructive pulmonary disease.

6 Dec 2011

Measles raises its head again in Europe after years of suppression: Report

According to a new report last Thursday, measles incidence is on the rise in Europe following decades of decline. Up to October European health officials reported more than 26,000 measles cases this year and nine deaths.

5 Dec 2011

HRF inhibitors may provide new therapeutic avenue for treatment of asthma and allergies

La Jolla Institute for Allergy & Immunology scientists have identified the histamine releasing factor (HRF) molecule as a promising target for developing new treatments for a number of allergic reactions including asthma.

3 Dec 2011

La Jolla researchers create first cellular movies showing destruction underlying type 1 diabetes

A war is being waged in the pancreases of millions of people throughout the world. The siege leads to the development of type 1 diabetes and has been a battlefield largely hidden from view-- until now.

3 Dec 2011

Researchers discover why men more likely than women to develop squamous cell skin cancer

Men are three times more likely than women to develop a common form of skin cancer but medical science doesn't know why. A new study may provide part of the answer.

2 Dec 2011

Even those with egg allergies should receive the flu vaccine

With the coughing, sneezing and achy flu season upon us, new recommendations say that even those with egg allergies should receive the flu vaccine.

1 Dec 2011

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Speaking today at the plenary session of the 7th Annual European Antibody Congress in Geneva, Dr. Anat Cohen-Dayag, President and CEO of Compugen Ltd., presented Compugen's Antibody Target Discovery Platform, one of the Company's predictive discovery platforms for novel therapeutic targets.

1 Dec 2011

Oral ingestion of apple polyphenols can prevent colitis in mice

Here's another reason why "an apple a day keeps the doctor away"-according to new research findings published in the Journal of Leukocyte Biology, oral ingestion of apple polyphenols can suppress T cell activation to prevent colitis in mice.

1 Dec 2011

Immunology News and Research

Latest Immunology News and Research

New cost-effective liquid solution can help fight antibiotic-resistant bacteria

Study describes miR-124 can prevent and treat liver cancer

New guidelines for managing latent tuberculosis from CDC

High gut flora protects children against allergies

Pharmacyclics, Janssen partner to develop and market PCI-32765 anti-cancer compound

Recommendations to address challenges associated with chronic inflammatory diseases

Janssen Biotech, Molecular Partners collaborate to develop DARPins for immunological diseases

Vaccine against Ebola developed

Milk powder outperforms lower-dose therapy for treatment of food allergies

Advancing the development of a malaria transmission-blocking vaccine

More mothers are breastfeeding their newborns, but for too short a duration

Headaches after TBI more prevalent among adolescents, girls

Dust storms have adverse effect on hospital EDs for COPD

Measles raises its head again in Europe after years of suppression: Report

HRF inhibitors may provide new therapeutic avenue for treatment of asthma and allergies

La Jolla researchers create first cellular movies showing destruction underlying type 1 diabetes

Researchers discover why men more likely than women to develop squamous cell skin cancer

Even those with egg allergies should receive the flu vaccine

Compugen's Antibody Target Discovery Platform presented at 7th Annual European Antibody Congress

Oral ingestion of apple polyphenols can prevent colitis in mice

Immunology eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey